Macrogen Adds Expertise To Expanding Asian Genomics Project
This article was originally published in PharmAsia News
Executive Summary
South Korea’s Macrogen is to participate in the GenomeAsia 100K project, which aims to generate extensive genomic information for Asian populations and promote genetic understanding to support drug research and discovery, with the ultimate aim of accelerating precision medicine applications for ‘underrepresented’ Asian patients.